Restructuring and Related Charges (Tables)

12 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

The following table summarizes the change in the Company’s restructuring and other related liabilities for the years ended December 31, 2025, 2024, and 2023 (in thousands):


	Severance and other employee- related benefits(1)			Facility Costs			Other(2)			Total
Balance at December 31, 2022	$	4,014		$	—		$	19		$	4,033
Restructuring and related charges		2,379			4,160			537			7,076
Cash payments		(5,568	)		(4,160	)		(556	)		(10,284	)
Balance at December 31, 2023		825			—			—			825
Restructuring and related charges		8,988			2,779			733			12,500
Cash payments		(8,232	)		(2,779	)		(733	)		(11,744	)
Balance at December 31, 2024		1,581			—			—			1,581
Restructuring and related charges		11,306			3,048			428			14,782
Cash payments		(9,971	)		(3,048	)		(428	)		(13,447	)
Balance at December 31, 2025	$	2,916		$	—		$	—		$	2,916

(1)

Restructuring liabilities are recorded in accrued liabilities on the consolidated balance sheets. Substantially all severance and other employee-related benefits related to ongoing benefit arrangements and were recorded pursuant to ASC 712.

(2)

Other restructuring liabilities are comprised mainly of sublease commissions and are recorded in other accrued liabilities on the consolidated balance sheets.

STANDARD BIOTOOLS INC. 10-K